Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Michael

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
International Journal of Surgery Case Reports|March 16, 2026
Vaginal foreign body for contraceptive purposes resulting in vesicovaginal fistula in an unmarried nulliparous woman: a case reportMpoyi Mukeba Constantin, Abidan Josia Mganga, Elizabeth Michael Temu, et al.
Virology|April 18, 2006
Dominant-negative effect of hetero-oligomerization on the function of the human immunodeficiency virus type 1 envelope glycoprotein complexCarolina Herrera, Per Johan Klasse, Christopher W Kibler, et al.
Virology|May 26, 2005
Neutralization sensitivity of HIV-1 Env-pseudotyped virus clones is determined by co-operativity between mutations which modulate the CD4-binding site and those that affect gp120-gp41 stabilitySimon Beddows, Natalie N Zheng, Carolina Herrera, et al.
Virology|March 24, 2009
Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densitiesPavel Pugach, Neelanjana Ray, Per Johan Klasse, et al.
AIDS Research and Human Retroviruses|April 10, 2010
IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccinesKaustuv Banerjee, P J Klasse, Rogier W Sanders, et al.
AIDS Research and Human Retroviruses|July 29, 2011
Occluding the mannose moieties on human immunodeficiency virus type 1 gp120 with griffithsin improves the antibody responses to both proteins in miceKaustuv Banerjee, Elizabeth Michael, Dirk Eggink, et al.
Virology|June 4, 2005
The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particlesCarolina Herrera, Per Johan Klasse, Elizabeth Michael, et al.
Virology|May 5, 2009
Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivoKaustuv Banerjee, Sofija Andjelic, Per Johan Klasse, et al.
Journal of Virology|July 5, 2005
Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1Simon Beddows, Norbert Schülke, Marc Kirschner, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|September 8, 2022
Patient perspectives on primary care for multimorbidity: An integrative reviewElaine Moody, Ruth Martin-Misener, Larry Baxter, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
International Journal of Surgery Case Reports|March 16, 2026
Vaginal foreign body for contraceptive purposes resulting in vesicovaginal fistula in an unmarried nulliparous woman: a case reportMpoyi Mukeba Constantin, Abidan Josia Mganga, Elizabeth Michael Temu, et al.
Virology|April 18, 2006
Dominant-negative effect of hetero-oligomerization on the function of the human immunodeficiency virus type 1 envelope glycoprotein complexCarolina Herrera, Per Johan Klasse, Christopher W Kibler, et al.
Virology|May 26, 2005
Neutralization sensitivity of HIV-1 Env-pseudotyped virus clones is determined by co-operativity between mutations which modulate the CD4-binding site and those that affect gp120-gp41 stabilitySimon Beddows, Natalie N Zheng, Carolina Herrera, et al.
Virology|March 24, 2009
Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densitiesPavel Pugach, Neelanjana Ray, Per Johan Klasse, et al.
AIDS Research and Human Retroviruses|April 10, 2010
IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccinesKaustuv Banerjee, P J Klasse, Rogier W Sanders, et al.
AIDS Research and Human Retroviruses|July 29, 2011
Occluding the mannose moieties on human immunodeficiency virus type 1 gp120 with griffithsin improves the antibody responses to both proteins in miceKaustuv Banerjee, Elizabeth Michael, Dirk Eggink, et al.
Virology|June 4, 2005
The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particlesCarolina Herrera, Per Johan Klasse, Elizabeth Michael, et al.
Virology|May 5, 2009
Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivoKaustuv Banerjee, Sofija Andjelic, Per Johan Klasse, et al.
Journal of Virology|July 5, 2005
Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1Simon Beddows, Norbert Schülke, Marc Kirschner, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|September 8, 2022
Patient perspectives on primary care for multimorbidity: An integrative reviewElaine Moody, Ruth Martin-Misener, Larry Baxter, et al.
Pageof 3